Association Between FIASMA Psychotropics and COVID-19

Psychopharmacology and Psychiatry Updates - Een podcast door Psychopharmacology Institute

What are FIASMA psychotropics? What do they have to do with COVID-19? In this episode, we discuss a recent study that compared rates of severe illness among patients who, when admitted for COVID-19, were or were not taking a FIASMA—a functional inhibitor of acid sphingomyelinase activity. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 40 Association Between FIASMA Psychotropic Medications and Reduced Risk of Intubation or Death in Individuals With Psychiatric Disorders Hospitalized for Severe COVID-19: An Observational Multicenter Study

Visit the podcast's native language site